Cytokinetics Inc. buy Royal Bank of Canada
Start price
07.05.25
/
50%
€29.40
Target price
07.05.26
€70.52
Performance (%)
112.86%
End price
08.05.26
€62.58
Summary
This prediction ended on 08.05.26 with a price of €62.58. With a performance of 112.86% the BUY prediction by Royal_Bank_of_Canada was a big success. Royal_Bank_of_Canada has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -1.874% | -1.874% | 136.815% |
| iShares Core DAX® | -2,68 % | 4,26 % | 2,12 % |
| iShares Nasdaq 100 | 0,73 % | 5,80 % | 34,20 % |
| iShares Nikkei 225® | -0,73 % | 9,32 % | 61,30 % |
| iShares S&P 500 | 1,17 % | 5,48 % | 24,75 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Royal Bank of Canada from $82.00 to $80.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€55.50
11.11.25
11.11.25
€75.30
11.11.26
11.11.26
33.98%
10.07.26
10.07.26
Stopped prediction by Royal_Bank_of_Canada for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€57.50
20.02.26
20.02.26
€85.91
20.02.27
20.02.27
29.32%
10.07.26
10.07.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€54.00
21.01.26
21.01.26
€81.00
21.01.27
21.01.27
37.70%
10.07.26
10.07.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.80
18.12.24
18.12.24
€78.17
18.12.25
18.12.25
14.63%
19.12.25
19.12.25